A NEW CANDIDATE DRUG FOR NEUROPROTECTIVE TREATMENT IN GLAUCOMA


Purpose:To investigate the effect of K-115, a novel Rho kinase inhibitor, on retinal ganglion cell (RGC) death in an optic nerve crush (NC) model.  

Conclusions:The results delayed that oral K-115 administration inhibited RGC death...Our findings show that K-115 has a potential use in neuroprotective treatment for glaucoma and other neurodegenerative diseases.

Comments

Popular posts from this blog

IMPLANTABLE COLLAMER LENS APPEARS BETTER THAN LASIK OR PRK FOR MODERATE TO HIGH MYOPIC PATIENTS

RINSING YOUR CONTACT LENS CASE IS NOT ENOUGH